ID   TMHepTG2984 2
AC   CVCL_B6DM
SY   TMHepTG2984 line 2; TM hep TG 2984/2
DR   Wikidata; Q112041799
RX   PubMed=1369183;
RX   PubMed=1711473;
CC   Characteristics: Established from a transgenic mice that contains a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1 (PubMed=1369183).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: Myc.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x SJL transgenic TG2984.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=1369183; DOI=10.1007/BF02521733;
RA   Perraud F., Dalemans W., Ali-Hadji D., Pavirani A.;
RT   "Novel cell lines derived from transgenic mice expressing recombinant
RT   human proteins. Transgenic hepatoma-derived cell lines.";
RL   Cytotechnology 9:69-75(1992).
//
RX   PubMed=1711473; DOI=10.1016/0014-4827(91)90500-t;
RA   Perraud F., Dalemans W., Gendrault J.-L., Dreyer D., Ali-Hadji D.,
RA   Faure T., Pavirani A.;
RT   "Characterization of trans-immortalized hepatic cell lines established
RT   from transgenic mice.";
RL   Exp. Cell Res. 195:59-65(1991).
//